Made With Uberflip Content Marketing

Investing

Venture capitalists and other investors in biotech discuss the ins and outs of investing.

  • 2016 – A Year in Review for Advanced Therapies

    2016 – A Year in Review for Advanced Therapies

    Guest post by Patricia Reilly, M.S., Head of Intelligence Alliances and Unification, Pharma Intelligence | Informa The past year saw intensifying dialogue on how to assess the value of and...

    Read
  • Stirring the Pot for Entrepreneurship in European Tech Transfer

    Stirring the Pot for Entrepreneurship in European Tech Transfer

    Guest post by Luke Timmerman, founder and editor of the Timmerman Report, and a regular contributor to Forbes and STAT News. The science in many parts of Europe is first-rate. No one disputes...

    Read
  • Increase the value of your asset: Think with the end in mind

    Increase the value of your asset: Think with the end in mind

    Developing a drug is a very long journey, therefore it is critical to define the destination upfront. The Target Product Profile is like a postcard of your desired destination. It informs the data...

    Read
  • What’s the deal with Immuno-oncology partnering?

    What’s the deal with Immuno-oncology partnering?

    Insight wanted to get the lay of the I/O landscape, so who better to speak with than Jeff Bockman, Vice President of Defined Health. Not only was Jeff kind enough to share his insights with us,...

    Read
  • Biotech Showcase™ 2017: Q BioMed plans to accelerate up to four more assets6:07

    Biotech Showcase™ 2017: Q BioMed plans to accelerate up to four more assets

    Established in June 2015, Q BioMed, the NYC-based biomedical acceleration development company, is looking to add three to four more assets to its portfolio. Company founder and CEO, Denis Corin, outli

    Watch Video
  • Why the connected patient is the killer app in the digital age of medicine

    Why the connected patient is the killer app in the digital age of medicine

    Guest article by Deb Kilpatrick, PhD, CEO at Evidation Health and Rich Milani, MD, FACC, FAHA, Chief Clinical Transformation Officer at Ochsner Health System If you search on the phrase “killer...

    Read
  • Breaking down the “four walls” of patient care: What is the state of the digital medicine industry?

    Breaking down the “four walls” of patient care: What is the state of the digital medicine industry?

    Amid tirelessly pursuing possible partnerships and investment opportunities to bring revolutionary medical products to market at Biotech Showcase™ 2017 in San Francisco, global executives were...

    Read
  • Welcome to Barcelona—one of the most vibrant life sciences hubs in Europe

    Welcome to Barcelona—one of the most vibrant life sciences hubs in Europe

    Guest article by BIOCAT, the Bioregion of Catalonia After the great success of previous editions (2010 and 2013), the Bioregion of Catalonia is again hosting BIO-Europe Spring® 2017 (March 20–22),...

    Read
  • Pulse, prognosis and the press: Journalists discuss key biotech trends for 2017

    Pulse, prognosis and the press: Journalists discuss key biotech trends for 2017

    As the intensity of Biotech Week in San Francisco winds down, join our exclusive panel of all-star reporters for their unique take on the news, trends and issues that will reverberate in 2017 and...

    Read
  • Unmet needs, uncommon commitment: The shift toward investment in rare diseases

    Unmet needs, uncommon commitment: The shift toward investment in rare diseases

    Join biotech leaders, emerging innovators, investors and patient advocacy group reps for a candid, interactive and enlightening discussion about rare disease drug discovery and development. Read...

    Read
  • Biotech Showcase™ 2017: The financial continuum and value creation57:08

    Biotech Showcase™ 2017: The financial continuum and value creation

    Biotech financial markets were buffeted by the winds of macro-economic events in 2016 ranging from the Brexit vote to the unprecedented presidential election in the US. In this new year we will take s

    Watch Video
  • Digital medicine: Invest in innovation

    Digital medicine: Invest in innovation

    It’s too soon to say, definitively, whether digital medicine will be disruptive or adjunctive for drug developers or even the entire healthcare system. Even the business models are in flux. What...

    Read
  • Who gets funded? Imaginative companies!

    Who gets funded? Imaginative companies!

    The biotech industry needs a new approach that approximates the type of disruption that Uber brought to transportation and Amazon and eBay brought to retail sales. Instead of embracing those lean...

    Read
  • UK Establishment upbeat about Brexit’s effect on British life science industry

    UK Establishment upbeat about Brexit’s effect on British life science industry

    Brexit may no longer be at the top of popular news, but it continues to be a key concern for biopharma companies in post-Brexit 2017. The sentiment of key players from the UK life sciences from a...

    Read
  • Finding Finance: Pharma, Biotech & Medtech Capital Raising 2016

    Finding Finance: Pharma, Biotech & Medtech Capital Raising 2016

    Read Flipbook
  • Taming the Wild West of digital medicine

    Taming the Wild West of digital medicine

    The new paradigm of healthcare is widely becoming known as “The Digital Health Revolution,” referring to medical technology advancements so great that when combined with wearables, medication...

    Read
  • Investors’ appetite for the life sciences continued in 2016

    Investors’ appetite for the life sciences continued in 2016

    Guest post by Doro Shin, Thought Leadership Manager at Informa Pharma Intelligence While 2015 was a record year for investments within the life sciences industry, investors became wary toward the...

    Read
  • It’s all happening at Biotech Showcase™ Week

    It’s all happening at Biotech Showcase™ Week

    Guest post by Constantine Theodoropulos, President, GO Therapeutics Thankfully there is a holiday between now and Biotech Showcase™ Week in San Francisco (Jan 9–11), because we are going to need...

    Read
  • Lifetime trends in biopharmaceutical innovation: Recent evidence and implications

    Lifetime trends in biopharmaceutical innovation: Recent evidence and implications

    Guest blog post by Murray Aitken, Executive Director of the QuintilesIMS Institute Adequate returns on life sciences investments underpin the sustainability of the innovation lifecycle.   And...

    Read
  • Breaking news:  Creating a healthcare futures market

    Breaking news: Creating a healthcare futures market

    Dennis Purcell, founder and senior advisor of Aisling Capital LLC, and co-founder of Poliwogg, is creating a futures market for healthcare, mirroring healthcare consumption from diagnosis to...

    Read
  • loading
    Loading More...